Home › Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration
 

Keywords :   


Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration

2015-12-07 17:45:48| Biotech - Topix.net

Our regular management interview will be held on our subscription panel today at 11am EST with Dr Todd Brady, MD, PhD, CEO of Aldeyra . Please buy a discounted subscription to participate in the panel discussion, and other discussions held regularly for subscribers.

Tags: drug pricing collaboration digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11 Next%
15.112019 figma
15.11[] 5
15.11!!
15.11S11 NITRO 156cm
15.1115
15.1127.2mm
15.11 35
More »